Movement Alert｜10x Genomics, Inc. Falls 5.22% in Regular Trading, trading at $72.189

Market Focus10-22

On October 22, 10x Genomics, Inc. fell 5.22% in Regular Trading, trading at $72.189 per share, with Turnover of $39.1573 million.

Within the Life Sciences Tools & Services sector where 10x Genomics, Inc. belongs, peer moves were mixed. Among individual stocks, Qiagen NV up 0.4%, Danaher up 0.06%, Thermo Fisher Scientific down 1.07%, Medpace down 1.17%, and Charles River Laboratories up 1.25%.

The company develops and sells instruments, consumables, and software used to analyze biological systems, serving academic, government, biopharmaceutical, biotechnology, and other institutions across multiple regions.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment